Paid Clinical Trials in Anchorage, AK
As of June 2026, 115 paid clinical trials are recruiting in Anchorage, Alaska. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Anchorage offers studies at sites including Providence Alaska Medical Center for conditions such as Malignant Solid Neoplasm, Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Anchorage
Trials by drug in Anchorage
Filter results
116 clinical trials
↓ Download CSVBGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Jumpstarting Advance Care Planning With ANAI People
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Family-Based Financial Incentives Intervention for Smoking Cessation
More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers
About research studies in Anchorage
Anchorage has approximately 115 recruiting research studies across a wide range of therapeutic areas. Alaska hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Anchorage
Researchers run research studies in Anchorage, AK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Alaska Medical Center | Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Breast Cancer | 56 |
| Alaska Women's Cancer Care | Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma, Anatomic Stage IV Breast Cancer AJCC v8 | 50 |
| Katmai Oncology Group | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Recurrent Lung Non-Small Cell Carcinoma | 46 |
| Alaska Oncology and Hematology LLC | Malignant Solid Neoplasm, Breast Cancer, Chronic Lymphocytic Leukemia | 42 |
| Alaska Breast Care and Surgery LLC | Malignant Solid Neoplasm, Breast Cancer, Chronic Lymphocytic Leukemia | 41 |
| Anchorage Associates in Radiation Medicine | Malignant Solid Neoplasm, Breast Cancer, Chronic Lymphocytic Leukemia | 41 |
| Anchorage Radiation Therapy Center | Breast Cancer, Chronic Lymphocytic Leukemia, Malignant Solid Neoplasm | 32 |
| Anchorage Oncology Centre | Chronic Lymphocytic Leukemia, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain | 30 |
| Alaska Oncology and Hematology | Breast Neoplasms, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung | 8 |
| Alaska Heart Institute | Obstructive Hypertrophic Cardiomyopathy, Paroxysmal Atrial Fibrillation | 2 |
| Alaska Native Tribal Health Consortium | Child Obesity, Smoking Cessation | 2 |
| Alaska Oncology & Hematology, LLC | B-Cell Non-Hodgkins Lymphoma, Non-small Cell Lung Cancer | 2 |
| Alaska Oncology and Hematology, LLC | Non-small Cell Lung Cancer, Solid Tumours | 2 |
| Orthopedic Physicians Alaska | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Uncontrolled Gout | 2 |
| Southcentral Foundation | Advance Care Planning, Hearing Loss | 2 |
| Alaska Womens Cancer Care | Endometrial Cancer, Malignant Neoplasm | 2 |
| AA Spine & Pain Clinic | Lumbar Spinal Stenosis | 1 |
| Alaska Children's EYE & Strabismus | Bradycardia, Strabismus | 1 |
| Alaska Heart and Vascular Institute | Symptomatic Hypertrophic Cardiomyopathy (HCM) | 1 |
| Alaska Native Medical Center (ANMC) | Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III | 1 |
| Alaska Oncology and Hematology, Llc | HR+/HER2- Breast Cancer | 1 |
| Alaska Women's Cancer Center | Endometrial Adenocarcinoma | 1 |
| Alaska Womens Cancer Care Akwcc | Ovarian Cancer | 1 |
| Anchorage Native Primary Care Center | Smoking Cessation | 1 |
| Investigative | Solid Tumors | 1 |
Active & Upcoming Studies in Anchorage (2026)
Recruiting trials in Anchorage grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (80 active studies)
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · Fred Hutchinson Cancer Center
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · Phase 3 · BeOne Medicines
Cardiovascular (3 active studies)
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
- STOP AF First Post-Approval Study · Medtronic Cardiac Ablation Solutions
Mental health & behavior (2 active studies)
- Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT) · Southcentral Foundation
- Family-Based Financial Incentives Intervention for Smoking Cessation · Mayo Clinic
Diabetes & metabolic (1 active study)
- More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers · Alaska Native Tribal Health Consortium
Pediatric (1 active study)
Common conditions studied in Anchorage
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- B Acute Lymphoblastic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Gastroesophageal Junction Adenocarcinoma (3 active studies). Recruiting Gastroesophageal Junction Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-small Cell Lung Cancer (3 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Anchorage
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Alaska are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Alaska research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Anchorage. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Anchorage
Hipa.ai aggregates every recruiting study in Anchorage from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Anchorage?
There are approximately 115 recruiting clinical trials in Anchorage, Alaska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Anchorage pay participants?
Most recruiting trials in Anchorage compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Anchorage?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Anchorage?
The most common conditions under active study in Anchorage include Malignant Solid Neoplasm (5), Breast Cancer (4), Anatomic Stage II Breast Cancer AJCC v8 (3), B Acute Lymphoblastic Leukemia (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Anchorage?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Anchorage on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Anchorage?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Anchorage?
Recruiting research sites in Anchorage include Providence Alaska Medical Center, Alaska Women's Cancer Care, Katmai Oncology Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Anchorage right now?
The largest active categories in Anchorage are Cancer & tumors (80), Cardiovascular (3), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.